202 related articles for article (PubMed ID: 14722252)
21. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
22. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
[TBL] [Abstract][Full Text] [Related]
23. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
24. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
Ittner LM; Koller D; Muff R; Fischer JA; Born W
Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
[TBL] [Abstract][Full Text] [Related]
25. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
26. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
Granholm S; Lundberg P; Lerner UH
J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
[TBL] [Abstract][Full Text] [Related]
27. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
28. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smooth muscle cells.
Frayon S; Cueille C; Gnidéhou S; de Vernejoul MC; Garel JM
Biochem Biophys Res Commun; 2000 Apr; 270(3):1063-7. PubMed ID: 10772950
[TBL] [Abstract][Full Text] [Related]
30. N-Glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CRLR/RAMP3 adrenomedullin receptor.
Flahaut M; Pfister C; Rossier BC; Firsov D
Biochemistry; 2003 Sep; 42(34):10333-41. PubMed ID: 12939163
[TBL] [Abstract][Full Text] [Related]
31. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
32. A potent and selective CGRP2 agonist, [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays.
Dumont Y; Fournier A; St-Pierre S; Quirion R
Can J Physiol Pharmacol; 1997 Jun; 75(6):671-6. PubMed ID: 9276147
[TBL] [Abstract][Full Text] [Related]
33. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
34. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy.
Nagae T; Mukoyama M; Sugawara A; Mori K; Yahata K; Kasahara M; Suganami T; Makino H; Fujinaga Y; Yoshioka T; Tanaka I; Nakao K
Biochem Biophys Res Commun; 2000 Apr; 270(1):89-93. PubMed ID: 10733909
[TBL] [Abstract][Full Text] [Related]
35. The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis.
Hwang IS; Tang F; Leung PP; Li YY; Fan ST; Luk JM
Regul Pept; 2006 Jul; 135(1-2):69-77. PubMed ID: 16713642
[TBL] [Abstract][Full Text] [Related]
36. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
[TBL] [Abstract][Full Text] [Related]
37. Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells.
Aiyar N; Disa J; Pullen M; Nambi P
Mol Cell Biochem; 2001 Aug; 224(1-2):123-33. PubMed ID: 11693189
[TBL] [Abstract][Full Text] [Related]
38. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
Fraser NJ; Wise A; Brown J; McLatchie LM; Main MJ; Foord SM
Mol Pharmacol; 1999 Jun; 55(6):1054-9. PubMed ID: 10347248
[TBL] [Abstract][Full Text] [Related]
39. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
40. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2.
Tam CW; Husmann K; Clark NC; Clark JE; Lazar Z; Ittner LM; Götz J; Douglas G; Grant AD; Sugden D; Poston L; Poston R; McFadzean I; Marber MS; Fischer JA; Born W; Brain SD
Circ Res; 2006 Feb; 98(2):262-70. PubMed ID: 16373602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
